ECAU
PTLA

Everett Capital Advisors (UK)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Everett Capital Advisors (UK)’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-250,000
Closed -$4.88M – 40
2018
Q4 		$4.88M Sell
250,000
-188,100
-43% -$3.87M 1.01% 22
2018
Q3 		$11.7M Buy
438,100
+250,000
+133% +$8.16M 1.7% 17
2018
Q2 		$7.11M Sell
188,100
-47,400
-20% -$1.81M 0.49% 37
2018
Q1 		$7.69M Buy
235,500
+196,300
+501% +$8.61M 0.65% 36
2017
Q4 		$1.91M Buy
+39,200
New +$1.98M 0.29% 33

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Everett Capital Advisors (UK)'s PTLA Position: Q4 2018 in Review

Everett Capital Advisors (UK) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2018, closing a stake of 855,476 shares — an estimated $17.6M sold.

Everett Capital Advisors (UK) first reported a position in PTLA in Q3 2017 and held it in 5 quarters. The position peaked at $29.5M in Q2 2018. 181 funds tracked by Wall St. Rank hold PTLA as of Q4 2018.

  • Everett Capital Advisors (UK) reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Everett Capital Advisors (UK) sold 855,476 Portola Pharmaceuticals, Inc. shares in Q4 2018, an estimated $17.6M.
  • Everett Capital Advisors (UK) first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 5 quarters.
  • Everett Capital Advisors (UK)'s Portola Pharmaceuticals, Inc. position peaked at $29.5M in Q2 2018.
  • 181 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2018.

Based on Everett Capital Advisors (UK)'s 13F filing for Q4 2018, filed 13 Feb 2019.